Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Eur J Heart Fail
; 24(3): 581-588, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34693613
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Aortic Valve Stenosis
/
Transcatheter Aortic Valve Replacement
/
Heart Failure
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Eur J Heart Fail
Journal subject:
CARDIOLOGIA
Year:
2022
Type:
Article
Affiliation country:
Spain